Immunological
1877 — British clinical literature (Jonathan Hutchinson's report of 'Mortimer's malady,' London)
Sarcoidosis was first described in the late nineteenth century through independent clinical observations made by dermatologists and physicians in Europe who noted unusual granulomatous skin lesions that did not conform to known infectious diseases of the era. For decades, the condition was understood primarily as a disorder of the skin before physicians recognized its capacity to involve internal organs. The history of sarcoidosis is largely one of gradual expansion in understanding, as successive generations of clinicians connected seemingly unrelated findings across multiple organ systems into a unified disease concept.
Historical Narrative
The earliest recognizable clinical description of sarcoidosis appeared in 1877, when the British dermatologist Jonathan Hutchinson reported a patient presenting with symmetrical, raised purplish skin plaques on the hands and feet. Hutchinson called the condition 'Mortimer's malady' after his patient and initially classified it as a peculiar form of gout. He did not recognize it as part of a systemic process, and his interpretation remained rooted in the dermatological thinking of the Victorian era.
In 1889, the French dermatologist Ernest Besnier described a similar cutaneous condition he termed 'lupus pernio,' characterized by violaceous plaques affecting the nose, cheeks, and ears. Besnier considered this a variant of lupus rather than a distinct entity, and the relationship between his observations and Hutchinson's was not immediately appreciated. Norwegian dermatologist Caesar Boeck subsequently described multiple cases of skin lesions featuring distinctive microscopic clusters of cells, which he named 'multiple benign sarkoid of the skin' in 1899, coining the term that would eventually give the disease its name. Boeck believed the condition was benign and self-limiting.
The realization that the disease extended well beyond the skin came incrementally. Norwegian physician Jørgen Schaumann published extensive research between 1914 and 1934 demonstrating that what Hutchinson, Besnier, and Boeck had described were all manifestations of a single systemic condition capable of involving the lymph nodes, lungs, liver, spleen, and bones. Schaumann argued strenuously for a unified disease concept and proposed that the condition might have an infectious origin, though he could not identify a causative agent. His insistence on the systemic nature of the disease was a pivotal advance.
Early twentieth-century physicians frequently confused sarcoidosis with tuberculosis because both conditions produced granulomatous tissue changes visible under the microscope. This diagnostic confusion was not merely academic; it influenced how patients were managed in sanatoria and clinics across Europe and North America for decades. The tuberculin skin test was sometimes employed to help distinguish the two conditions, as many sarcoidosis patients showed diminished reactivity to tuberculin, a phenomenon that itself became a subject of intense investigation.
Swedish physician Sven Löfgren described a specific acute presentation of the condition in 1952, characterized by the combination of bilateral enlarged lymph nodes at the lung roots, joint inflammation, and skin lesions. This constellation, subsequently called Löfgren syndrome, helped clinicians recognize a more acute and often self-resolving form of the disease and distinguished it from chronic presentations. Löfgren's work helped bring greater precision to a diagnostic landscape that had long been characterized by ambiguity.
The development of chest radiography in the early twentieth century transformed the ability of physicians to detect pulmonary involvement, and by mid-century researchers had proposed classification schemes based on radiographic patterns. The Kveim test, introduced in the 1940s by Norwegian physician Morten Kveim, involved injecting splenic tissue from affected patients to elicit a granulomatous skin reaction, and was widely used for several decades as a diagnostic aid before concerns about its standardization and safety eventually led to its abandonment. Throughout the twentieth century, the question of whether sarcoidosis had an infectious, autoimmune, or environmental trigger remained fiercely debated among pathologists, pulmonologists, and immunologists.
Key Historical Figures
Historical narrative only — this page describes how Sarcoidosis was understood historically. It is not medical advice and does not describe current diagnosis or treatment. Sourced from verified medical history references (NIH, Encyclopaedia Britannica, and standard medical history texts). See our medical disclaimer.